{"id":"mutaflor","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["EcN","Mutaflor","Newborn","Nissle","Prophylaxis"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:56:09.969Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04608851","phase":"PHASE4","title":"Preventing Urinary Tract Infections With E. Coli Nissle:","status":"UNKNOWN","sponsor":"University of Oulu","startDate":"2021-01-18","conditions":"Urinary Tract Infections in Children, Secondary Prevention","enrollment":530},{"nctId":"NCT04969679","phase":"PHASE4","title":"Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.","status":"COMPLETED","sponsor":"Kangbuk Samsung Hospital","startDate":"2018-03-16","conditions":"Ulcerative Colitis","enrollment":134},{"nctId":"NCT04787276","phase":"NA","title":"Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy","status":"COMPLETED","sponsor":"Bogomolets National Medical University","startDate":"2017-01-10","conditions":"Hepatic Encephalopathy, Liver Cirrhosis, End Stage Liver DIsease","enrollment":42},{"nctId":"NCT03800147","phase":"NA","title":"Effects of Nutritional Fat on the Growth of Intestinal E. Coli","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2019-01-24","conditions":"Escherichia Coli Infections","enrollment":40},{"nctId":"NCT02706184","phase":"PHASE3","title":"E. Coli Nissle in Oncology","status":"COMPLETED","sponsor":"University of Hohenheim","startDate":"2015-07","conditions":"Gastric Cancer, Colorectal Cancer","enrollment":20},{"nctId":"NCT02726295","phase":"PHASE4","title":"The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study","status":"COMPLETED","sponsor":"Keimyung University Dongsan Medical Center","startDate":"2016-09","conditions":"Constipation","enrollment":112},{"nctId":"NCT02144948","phase":"PHASE3","title":"Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2014-08","conditions":"Diabetes Mellitus Type II","enrollment":10},{"nctId":"NCT02953171","phase":"NA","title":"Probiotics in the Treatment of Irritable Bowel Syndrome","status":"UNKNOWN","sponsor":"University of Copenhagen","startDate":"2016-09","conditions":"Irritable Bowel Syndrome","enrollment":140},{"nctId":"NCT01540162","phase":"","title":"Experience of Mutaflor Suspension Use in Preterm Infants for Immunity Improvement","status":"COMPLETED","sponsor":"Odessa National Medical University","startDate":"2011-03","conditions":"Neonatal Infection","enrollment":62},{"nctId":"NCT02276508","phase":"PHASE1","title":"Open Label Trial of Nissle 1917","status":"COMPLETED","sponsor":"Elizabeth Lucas","startDate":"2014-10","conditions":"Urinary Tract Infections","enrollment":20},{"nctId":"NCT01696227","phase":"","title":"Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2012-07","conditions":"Recurrent UTIs, Catheter-Related Infections","enrollment":50},{"nctId":"NCT01772615","phase":"PHASE4","title":"Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2011-05","conditions":"Ulcerative Colitis","enrollment":100},{"nctId":"NCT01469273","phase":"PHASE4","title":"Prophylaxis of Gastrointestinal Infections With EcN","status":"UNKNOWN","sponsor":"Hospital San Bartolome","startDate":"2011-11","conditions":"Infantile Diarrhea","enrollment":198},{"nctId":"NCT01013259","phase":"PHASE2","title":"Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2009-02","conditions":"Rhinoconjunctivitis","enrollment":34}],"_emaApprovals":[],"_faersSignals":[{"count":20,"reaction":"DIARRHOEA"},{"count":13,"reaction":"FAECALOMA"},{"count":12,"reaction":"ABDOMINAL PAIN LOWER"},{"count":11,"reaction":"ABDOMINAL PAIN"},{"count":9,"reaction":"COLITIS ULCERATIVE"},{"count":8,"reaction":"PNEUMONIA"},{"count":6,"reaction":"ASTHENIA"},{"count":6,"reaction":"FATIGUE"},{"count":6,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":6,"reaction":"TACHYCARDIA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":36,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Mutaflor","genericName":"Mutaflor","companyName":"Charite University, Berlin, Germany","companyId":"charite-university-berlin-germany","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}